An 18-year follow-up after the first successful heart-lung transplant in Poland. Authors’ tribute to the pioneers of heart and lung transplantation

Zembala, Marian; Religa, Z; Large, Stephen; Perdeus, Jakub; Wojarski, Jacek; Nowalany-Kozielska, Ewa; Małyszek‐Tumidajewicz, Justyna; Zawadzki, Fryderyk; Wajda-Pokrontka, Marta; Ochman, Marek

doi:10.33963/kp.15420

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may be especially the case in Eisenmenger syndrome with an inoperable heart defect [5]. It should be noted that the last successful lung and heart transplant in Poland took place in 2001 [15], and ISHLT reports only a few dozen such procedures per year [12].…”

Section: Criteria For Referring a Patient To A Lung Transplant Center...mentioning

confidence: 99%

Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation

et al. 2022

View full text Add to dashboard Cite

Pulmonary arterial hypertension is a rare but progressive disease that leads to death. Modern drug treatment slows the progression of the disease and prolongs patients' lives, but often, even maximal treatment with parenteral prostacyclin does not prevent deterioration. In the case of inadequate clinical response to drug treatment, lung transplantation (LTx) should be considered. This article aims to analyze thoroughly indications to refer a patient for consultation with a transplant center, the optimal timing of listing for LTx, contraindications for the procedure, bridging techniques, as well as tests needed before and after transplantation. We outline the technique of the procedure and evaluate psychological aspects of LTx.

show abstract

Section: Criteria For Referring a Patient To A Lung Transplant Center...mentioning

confidence: 99%

Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The same parameter among patients who underwent such procedures and survived for at least 1 year was approximately 10.7 years. In this aspect, our facility has some experience, as the longest survival after such a procedure among our patients was 19 years [ 71 ]. The patient remained under our follow-up care.…”

Section: Thoracic Organ Transplantationmentioning

confidence: 99%

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension

Stącel

Latos

Urlik

et al. 2021

JCM

Self Cite

View full text Add to dashboard Cite

Despite significant advancements in pharmacological treatment, interventional and surgical options are still viable treatments for patients with pulmonary arterial hypertension (PAH), particularly idiopathic PAH. Herein, we review the interventional and surgical treatments for PAH. Atrial septostomy and the Potts shunt can be useful bridging tools for lung transplantation (Ltx), which remains the final surgical treatment among patients who are refractory to any other kind of therapy. Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) remains the ultimate bridging therapy for patients with severe PAH. More importantly, VA-ECMO plays a crucial role during Ltx and provides necessary left ventricular conditioning during the initial postoperative period. Pulmonary denervation may potentially be a new way to ensure better transplant-free survival among patients with the aforementioned disease. However, high-quality randomized controlled trials are needed. As established, obtaining the Eisenmenger physiology among patients with severe pulmonary hypertension by creating artificial defects is associated with improved survival. However, right-to-left shunting may be harmful after Ltx. Closure of the artificially created defects may carry some risk associated with cardiac surgery, especially among patients with Potts shunts. In conclusion, PAH requires an interdisciplinary approach using pharmacological, interventional, and surgical modalities.

show abstract

An 18-year follow-up after the first successful heart-lung transplant in Poland. Authors’ tribute to the pioneers of heart and lung transplantation

Cited by 2 publications

References 0 publications

Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation

Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension

Contact Info

Product

Resources

About